» Authors » Leila Rooshenas

Leila Rooshenas

Explore the profile of Leila Rooshenas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 641
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hole B, Rooshenas L, Morton R, Caskey F, Scanlon M, Coast J, et al.
BMJ Open . 2025 Mar; 15(3):e095185. PMID: 40054865
Objectives: Older people with kidney failure often have a limited range of treatment options, with few being well enough to receive a transplant. Instead, they either start dialysis or have...
2.
Coulman K, Elliott L, Blencowe N, Yeung J, Rooshenas L, Hinchliffe R, et al.
BJA Open . 2025 Feb; 13:100374. PMID: 39991708
Background: Interventions from RCTs can only be replicated and implemented if reported in sufficient detail. This study developed frameworks to assist researchers with describing, monitoring, and reporting the key components...
3.
Farrar N, Elliott D, Jepson M, Young B, Donovan J, Conefrey C, et al.
Trials . 2024 Dec; 25(1):829. PMID: 39695876
Background: Although the challenges of recruiting to randomised controlled trials (RCTs) are well documented, few studies have focused on the impact that the communication between recruiters and patients has on...
4.
Worthington J, Soundy A, Frost J, Rooshenas L, MacNeill S, Realpe Rojas A, et al.
Trials . 2024 Oct; 25(1):688. PMID: 39420412
Background: Chronic kidney disease (CKD) prevalence is steadily increasing, in part due to increased multimorbidity in our aging global population. When progression to kidney failure cannot be avoided, people need...
5.
Hole B, Coast J, Caskey F, Selman L, Rooshenas L, Kimpton G, et al.
Kidney Int . 2024 Oct; 107(1):130-142. PMID: 39368742
Most older people with kidney failure choose between treatment with dialysis or conservative kidney management. The preferences underlying these decisions are poorly understood. Here, we performed a choice experiment, informed...
6.
Janiaud P, Zecca C, Salmen A, Benkert P, Schadelin S, Orleth A, et al.
Trials . 2024 Sep; 25(1):607. PMID: 39261900
Background: Treatment decisions for persons with relapsing-remitting multiple sclerosis (RRMS) rely on clinical and radiological disease activity, the benefit-harm profile of drug therapy, and preferences of patients and physicians. However,...
7.
Jones T, McNair A, McLeod H, Morley J, Rooshenas L, Hollingworth W
J Health Serv Res Policy . 2024 May; 29(4):223-229. PMID: 38725100
Objectives: High variation in clinical practice may indicate uncertainty and potentially low-value care. Methods to identify low value care are often not well defined or transparent and can be time...
8.
Hoffmann C, Avery K, Macefield R, Dvorak T, Snelgrove V, Blazeby J, et al.
JMIR Hum Factors . 2024 Apr; 11:e46698. PMID: 38598276
Background: Improving shared decision-making (SDM) for patients has become a health policy priority in many countries. Achieving high-quality SDM is particularly important for approximately 313 million surgical treatment decisions patients...
9.
Carrie S, Fouweather T, Homer T, OHara J, Rousseau N, Rooshenas L, et al.
Health Technol Assess . 2024 Mar; 28(10):1-213. PMID: 38477237
Background: The indications for septoplasty are practice-based, rather than evidence-based. In addition, internationally accepted guidelines for the management of nasal obstruction associated with nasal septal deviation are lacking. Objective: The...
10.
Hoffmann C, Avery K, Macefield R, Snelgrove V, Blazeby J, Hopkins D, et al.
BMJ Open . 2024 Jan; 14(1):e079155. PMID: 38238045
Introduction: High-quality shared decision-making (SDM) is a priority of health services, but only achieved in a minority of surgical consultations. Improving SDM for surgical patients may lead to more effective...